Centiva Capital’s BioNTech BNTX Stock Holding History

Centiva Capital’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$249K	Buy	+2,800	New	+$288K	﹤0.01%	1157
2023 Q1	–	Sell	-21,300	Closed	-$3.2M	–	1539
2022 Q4	$3.2M	Hold	21,300	–	–	0.09%	229
2022 Q3	$2.87M	Sell	21,300 -9,600	-31%	-$1.47M	0.05%	272
2022 Q2	$4.61M	Buy	30,900 +12,400	+67%	+$1.89M	0.11%	159
2022 Q1	$3.15M	Buy	18,500 +5,500	+42%	+$924K	0.06%	287
2021 Q4	$3.35M	Buy	13,000 +11,980	+1,175%	+$3.28M	0.07%	252
2021 Q3	$278K	Buy	+1,020	New	+$324K	0.02%	812

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Centiva Capital's BNTX Position: Q1 2026 in Review

Centiva Capital opened a new position in BioNTech (BNTX) in Q1 2026: 2,500 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #1226 among its holdings. This is a return to the name: Centiva Capital previously reported a position in BNTX as recently as Q1 2023.

Centiva Capital first reported a position in BNTX in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.41M in Q1 2022. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Centiva Capital held 2,500 shares of BioNTech worth $222K as of Q1 2026.
BioNTech was a new Centiva Capital position in Q1 2026.
BioNTech made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #1226 holding.
Centiva Capital first reported a position in BioNTech in Q2 2021 and has held it in 8 quarters since.
Centiva Capital's BioNTech position peaked at $1.41M in Q1 2022.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.